賴氨酰氧化酶(LOX)重組蛋白
Recombinant Lysyl Oxidase (LOX)
Protein-Lysine 6-Oxidase
- 編號RPC580Mu01
- 物種Mus musculus (Mouse，小鼠)相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌, 細胞外基質
- 預測分子量55.4kDa
- 實際分子量54kDa(差異分析請參閱說明書)
- 片段與標簽Pro207~Tyr411 with N-terminal His and GST Tag
- 緩沖液成份20mM Tris, 150mM NaCl, pH8.0, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點6.1
- 應用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 1008¥ 2520¥ 5040¥ 15120¥ 37800
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
產品包裝(模擬)
產品包裝(模擬)
Figure . Gene Sequencing (extract)
Figure. SDS-PAGE
通過ISO 9001、ISO 13485質量體系認證
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPC580Mu01 | 賴氨酰氧化酶(LOX)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC580Mu02 | 賴氨酰氧化酶(LOX)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC580Mu02 | 賴氨酰氧化酶(LOX)多克隆抗體 | WB; IHC; ICC; IP. |
| PAC580Mu01 | 賴氨酰氧化酶(LOX)多克隆抗體 | WB; IHC; ICC; IP. |
| LAC580Mu71 | 賴氨酰氧化酶(LOX)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| LAC580Mu81 | 賴氨酰氧化酶(LOX)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| SEC580Mu | 賴氨酰氧化酶(LOX)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMC580Mu | 賴氨酰氧化酶(LOX)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| American Journal of Hematology | The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms.[PubMed: 23494965] |
| Current Eye Research | High Glucose Induced Differential Expression of Lysyl Oxidase and Its Isoform in ARPE-19 Cells[Pubmed: 22966818] |
| European Journal of Surgical Oncology | Evaluation of serum lysyl oxidase as a blood test for colorectal cancer [Pubmed: 24246612] |
| Vaccine | Copia autorizada por CDR[Ingentaconnect: Source] |
| Arthritis & Rheumatology | Lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis[Pubmed: 24574233] |
| Eur J Surg Oncol.? | Evaluation of serum lysyl oxidase as a blood test for colorectal cancer[Pubmed:Pmc4237001] |
| BMC Cancer. | Ionizing radiation induces tumor cell lysyl oxidase secretion[Pubmed:Pmc4223762] |
| DNA Cell Biol. | Lysyl Oxidase Genetic Variants Affect Gene Expression in Cervical Cancer[Pubmed:24945327] |
| scandinavian journal of immunology | Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis[PubMed: 26095613] |
| Curr Eye Res | Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-? Levels and LOXL1 Genotype in Pseudoexfoliation[Pubmed:27116380] |
| journal of bone and mineral metabolism | LOX Fails to Substitute for RANKL in Osteoclastogenesis.[pubmed:27606829] |
| 38 | Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases.[pubmed:28445728] |
| Molecular Medicine Reports | Lysyl oxidase is involved in synovial hyperplasia and angiogenesis in rats with collagen?induced arthritis[pubmed:28901438] |
| Revista Espa?ola de Cardiología?(English?Edition) | A Global Assessment of Circulating Prolysyl Oxidase in Nonischemic Patients With Garden-variety Heart Failure With Preserved Ejection Fraction[Pubmed:29807761] |
| Molecular?Medicine?Reports | Lysyl oxidase inhibition via β-aminoproprionitrile hampers human umbilical vein endothelial cell angiogenesis and migration in vitro[Pubmed:29393489] |
| Thyroid | Lysyl Oxidase is a key player in BRAF/MAPK pathway-driven thyroid cancer aggressiveness[Pubmed: 30398411] |
| Am J Physiol Lung Cell Mol Physiol | Lysyl Oxidase Directly Contributes to Extracellular Matrix Production and Fibrosis in Systemic Sclerosis.[Pubmed: 33026236] |
| J Am Heart Assoc | Collagen Cross?\Linking Is Associated With Cardiac Remodeling in Hypertrophic Obstructive Cardiomyopathy[33356379] |